4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Privigen: new trials by email Literature Review of Privigen trials Research Report on Privigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc) IgPro20, IgPro10 - Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Completed | CSL Behring | 27 | 2019-09-19 | 2024-02-05 |
| Ig PRx in AECOPD: Pilot Study Intravenous immunoglobulin (IVIG), Normal Saline - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Ottawa Hospital Research Institute | 48 | 2016-09-01 | 2019-11-27 |
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Completed | Anders Perner | 100 | 2014-04-01 | 2016-09-30 |
| Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins intravenous immunoglobulin (IVIg) - Multiple System Atrophy | Phase 2 | Completed | University of Massachusetts, Worcester | 9 | 2008-06-01 | 2017-02-23 |
Fasciitis, Necrotizing (1) · Fournier Gangrene (1) · Gas Gangrene (1) · Multiple System Atrophy (1) · Pulmonary Disease, Chronic Obstructive (1) · Scleroderma, Diffuse (1) · Thyroid Dyshormonogenesis 2A (1)
Anders Perner (1) · CSL Behring (1) · Ottawa Hospital Research Institute (1) · University of Massachusetts, Worcester (1)
Australia (1) · Canada (1) · Denmark (1) · Germany (1) · Italy (1) · Poland (1) · United Kingdom (1) · United States (1)
Anders Perner, Professor (1) · Juthaporn Cowan, MD, PhD, FRCPC (1) · Peter Novak, MD, PhD (1)
PMID 23116538, PMID 27399982, PMID 28421246, PMID 30116551, PMID 31916575, PMID 34887657, PMID 39909490
2018 (1)